Laureate Psychiatric Clinic And Hospital, Inc Psychiatric Hospital (Medicare Certified) Location: 6655 South Yale Avenue, Tulsa, Oklahoma 74136 Ratings:NA Phone: (918) 481-4000 |
Parkside, Inc Psychiatric Hospital (Medicare Certified) Location: 1239 S Trenton Ave, Tulsa, Oklahoma 74120 Ratings:NA Phone: (918) 582-2131 |
Tulsa Center For Behavioral Health Psychiatric Hospital (Medicare Certified) Location: 2323 S Harvard Ave, Tulsa, Oklahoma 74114 Ratings:NA Phone: (918) 293-2140 |
Saint Francis Hospital Vinita, Inc Acute Care Hospital (Medicare Certified) Location: 735 North Foreman Street, Vinita, Oklahoma 74301 Ratings: Phone: (918) 256-7551 |
Wagoner Community Hospital Acute Care Hospital (Medicare Certified) Location: 1200 West Cherokee Street, Wagoner, Oklahoma 74467 Ratings: Phone: (918) 485-5514 |
Mercy Hospital Watonga, Inc Critical Access Hospital (Medicare Certified) Location: 500 North Clarence Nash Boulevard, Watonga, Oklahoma 73772 Ratings:NA Phone: (580) 623-7211 |
Jefferson County Hospital Critical Access Hospital (Medicare Certified) Location: Intersection Hyws 81 & 70, Waurika, Oklahoma 73573 Ratings:NA Phone: (580) 228-2344 |
Weatherford Regional Hospital, Inc Of Weatherford Critical Access Hospital (Medicare Certified) Location: 3701 E Main, Weatherford, Oklahoma 73096 Ratings: Phone: (580) 772-5551 |
Alliancehealth Woodward Acute Care Hospital (Medicare Certified) Location: 900 17th Street, Woodward, Oklahoma 73801 Ratings: Phone: (580) 254-8492 |
Integris Canadian Valley Hospital Acute Care Hospital (Medicare Certified) Location: 1201 Health Center Parkway, Yukon, Oklahoma 73099 Ratings: Phone: (405) 717-6800 |
News Archive
New data from Boehringer Ingelheim's interferon-free SOUND-C3 study were presented during the APASL Liver Week in Singapore. The Phase IIb study investigated the efficacy and safety of faldaprevir+ and deleobuvir+ (BI 207127) plus ribavirin in treatment-naïve patients with genotype-1b (GT-1b) hepatitis C virus (HCV),1 one of the most common types of HCV globally.2
Regado Biosciences, a privately held company leading the development of antithrombotic aptamers with active control agents, announced today that the European Patent Office (EPO) has notified the Company of its intent to grant a patent with claims directed to oligonucleotide modulators of blood coagulation factor aptamers in EP 1401853. This new patent grant in the Company's portfolio extends the scope and breadth of Regado's intellectual property estate.
Angiochem, Inc., a clinical-stage biotechnology company developing drugs that are uniquely capable of crossing the blood-brain barrier through LRP targeting, announced today that preclinical data on two of its oncology programs, ANG1005 and ANG1007, for the treatment of brain cancers, as well as data demonstrating the utility of Angiochem's EPiC platform to achieve efficient penetration rates in the brain and in cancer tumor tissue, will be highlighted at the 101st Annual meeting of the American Association for Cancer Research 2010.
The British Heart Foundation is to fund research exploring the link between Bisphenol A (BPA), a manmade chemical found in commonly used plastics, and heart disease.
After a successful 2016 pilot, Vanderbilt University Medical Center's Vigil Volunteers (V3) program — which pairs volunteers with dying patients who either have no known family or friends, or whose family and friends are unable to be with them — is expanding in 2017.
› Verified 3 days ago